GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Capsensixx AG (XTER:CPX) » Definitions » Research & Development

Capsensixx AG (XTER:CPX) Research & Development : €0.0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Capsensixx AG Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Capsensixx AG's Research & Development for the six months ended in Jun. 2024 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 was €0.0 Mil.

Capsensixx AG Research & Development Historical Data

The historical data trend for Capsensixx AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Capsensixx AG Research & Development Chart

Capsensixx AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only - - - - -

Capsensixx AG Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Capsensixx AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Capsensixx AG  (XTER:CPX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Capsensixx AG Research & Development Related Terms

Thank you for viewing the detailed overview of Capsensixx AG's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Capsensixx AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Capsensixx AG (XTER:CPX) » Definitions » Research & Development
Comparable Companies
FRA:2INV HAM:GBQ XTER:SVE FRA:PEH XTER:SGF XTER:M3BK XTER:PZS XTER:B7E XTER:EFF HAM:C9T BLK BX OSTO:INVE A TSX:BN KKR APO BK AMP XSWX:PGHN LSE:III
Traded in Other Exchanges
CPX:Germany
Address
Bettinastrasse 57-59, Frankfurt, DEU, D-60325
Website
https://www.capsensixx.de
Capsensixx AG is a provider of financial administration as a service. The company is divided into two segments namely Funds management, Administration and Accounting Segment which includes fund management and fund accounting; and Securitisations which provides Advisory services in the field of financial engineering, securitisation and provision of director and administrative services to corporate clients in Luxembourg.

Capsensixx AG Headlines

No Headlines